We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Biosensing Advancement to Enable Early Detection of Disease Biomarkers at POC

By LabMedica International staff writers
Posted on 02 Jul 2025

Traditional medical diagnostics often require clinical samples to be sent off-site, leading to time-consuming and costly processes. More...

Point-of-care diagnostics offer a more efficient alternative, allowing rapid, low-cost testing at the site of patient care. However, current biosensor technologies still face challenges in detecting extremely low concentrations of disease biomarkers with high sensitivity and accuracy. One major issue is the fluorescence quenching caused by metal nanoparticles—particularly gold—when they are used to enhance signal detection, which limits the effectiveness of biosensors. Now, a new approach has been developed to overcome this sensitivity barrier by minimizing fluorescence quenching and enhancing detection capabilities for low-abundance biomarkers.

This solution, created by researchers at the Carl R. Woese Institute for Genomic Biology (Urbana, IL, USA), was inspired by photonic crystals found in nature, such as those responsible for the iridescent colors of peacock feathers. These nanostructures manipulate light based on their physical arrangement, not pigments, and have been harnessed for biosensing technologies. Previously, the team developed photonic crystal-based biosensors using gold nanoparticles to amplify fluorescence for biomarker detection. To improve upon this, the researchers introduced a new class of cryosoret nanoassemblies—precisely organized gold nanoparticle structures formed through rapid cryogenic freezing. They then integrated these nanoassemblies with engineered photonic crystals to enhance the fluorescence signal and reduce quenching. Building on this, they further developed magneto-plasmonic cryosoret nanoassemblies, which harness both the electric and magnetic components of light—an approach rarely used in biosensing systems. The team tested the platform using a common fluorophore and demonstrated that this dual-mode interaction achieved ultra-sensitive detection in the attomolar range while minimizing signal loss.

In their study published in MRS Bulletin and APL Materials, the researchers validated their solution, showing a 200-fold fluorescence enhancement compared to photonic crystals alone. These results confirmed that fluorescence quenching had been significantly reduced, improving the sensitivity of detection at very low biomarker concentrations. This hybrid optical platform offers enhanced light-matter interaction control at the nanoscale and could be used to detect biomarkers such as microRNAs, circulating tumor DNA, and viral particles, enabling earlier diagnosis of cancer and infectious diseases. The team now plans to optimize the cryosoret nanoassemblies further and develop intelligent, responsive biosensors with magnetic tunability for point-of-care use. They hope this technology will meet the urgent need for highly sensitive, accessible, and deployable diagnostic systems.

“This work represents a hybrid optical platform where photons are not merely emitted—they are orchestrated,” said Brian Cunningham, Professor of Electrical and Computer Engineering. “This convergence of photonic-plasmonic simulations, advanced nanofabrication, and chemical engineering principles has far-reaching implications, particularly in the realm of medical diagnostics.”

Related Links:
Carl R. Woese Institute for Genomic Biology


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Quality Control Material
Multichem ID-B
New
Drug Test Kit
DrugCheck 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.